Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity

被引:0
|
作者
K Watcharanurak
L Zang
M Nishikawa
K Yoshinaga
Y Yamamoto
Y Takahashi
M Ando
K Saito
Y Watanabe
Y Takakura
机构
[1] Graduate School of Pharmaceutical Sciences,Department of Biopharmaceutics and Drug Metabolism
[2] Kyoto University,Department of Human Health Science
[3] Graduate School of Medicine and Faculty of Medicine,Department of Molecular Microbiology
[4] Kyoto University,undefined
[5] Graduate School of Pharmaceutical Sciences,undefined
[6] Kyoto University,undefined
来源
Gene Therapy | 2014年 / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interferon γ (IFN-γ), an anticancer agent, is a strong inducer of indoleamine 2,3-dioxygenase 1 (IDO1), which is a tryptophan-metabolizing enzyme involved in the induction of tumor immune tolerance. In this study, we investigated the IDO1 expression in organs after IFN-γ gene transfer to mice. IFN-γ gene transfer greatly increased the mRNA expression of IDO1 in many tissues with the highest in the liver. This upregulation was associated with reduced L-tryptophan levels and increased L-kynurenine levels in serum, indicating that IFN-γ gene transfer increased the IDO activity. Then, Lewis lung carcinoma (LLC) tumor-bearing wild-type and IDO1-knockout (IDO1 KO) mice were used to investigate the effects of IDO1 on the antitumor activity of IFN-γ. IFN-γ gene transfer significantly retarded the tumor growth in both strains without any significant difference in tumor size between the two groups. By contrast, the IDO1 activity was increased only in the wild-type mice by IFN-γ gene transfer, suggesting that cells other than LLC cells, such as tumor stromal cells, are the major contributors of IDO1 expression in LLC tumor. Taken together, these results imply that IFN-γ gene transfer mediated IDO1 upregulation in cells other than LLC cells has hardly any effect on the antitumor activity of IFN-γ.
引用
收藏
页码:794 / 801
页数:7
相关论文
共 50 条
  • [1] Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity
    Watcharanurak, K. W
    Zang, L.
    Nishikawa, M.
    Yoshinaga, K.
    Yamamoto, Y.
    Takahashi, Y.
    Ando, M.
    Saito, K.
    Watanabe, Y.
    Takakura, Y.
    GENE THERAPY, 2014, 21 (09) : 794 - 801
  • [2] INDUCTION OF INDOLEAMINE 2,3-DIOXYGENASE - A MECHANISM OF THE ANTITUMOR-ACTIVITY OF INTERFERON-GAMMA
    OZAKI, Y
    EDELSTEIN, MP
    DUCH, DS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (04) : 1242 - 1246
  • [3] INDUCTION OF PULMONARY INDOLEAMINE 2,3-DIOXYGENASE BY INTERFERON
    YOSHIDA, R
    IMANISHI, J
    OKU, T
    KISHIDA, T
    HAYAISHI, O
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (01): : 129 - 132
  • [4] THE ROLE OF INDOLEAMINE 2,3-DIOXYGENASE IN THE ANTITUMOR-ACTIVITY OF HUMAN INTERFERON-GAMMA IN-VIVO
    BURKE, F
    KNOWLES, RG
    EAST, N
    BALKWILL, FR
    INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) : 115 - 122
  • [5] INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY IN HUMAN-MONOCYTES
    CARLIN, JM
    BORDEN, EC
    BYRNE, GI
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 374 - 374
  • [6] INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY IN HUMAN MONONUCLEAR PHAGOCYTES
    CARLIN, JM
    BORDEN, EC
    SONDEL, PM
    BYRNE, GI
    JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (01) : 29 - 34
  • [7] Overexpression of interferon-γ and indoleamine 2, 3-dioxygenase in systemic lupus erythematosus: relationship with the disease activity
    Mohammadi, Saeed
    Sedighi, Sima
    Memarian, Ali
    Yazdani, Yaghoub
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2017, 41 (01): : 41 - 47
  • [8] ANTITUMOR EFFECTS OF INTERFERON-GAMMA THROUGH INDUCTION OF INDOLEAMINE 2,3-DIOXYGENASE AND L-TRYPTOPHAN DEPRIVATION
    OZAKI, Y
    EDELSTEIN, MP
    DUCH, DS
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 744 - 744
  • [10] Induction of indoleamine 2,3-dioxygenase by interferon-γ in human islets
    Sarkar, Suparna A.
    Wong, Randall
    Hackl, Seija I.
    Moua, Ong
    Gill, Ronald G.
    Wiseman, Alexander
    Davidson, Howard W.
    Hutton, John C.
    DIABETES, 2007, 56 (01) : 72 - 79